Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease-Reference-Cited by-同舟云学术

Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease

Published:2012-09-13 Issue:11 Volume:27 Page:1392-1397
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov. Disord.

Author:

Ravina Bernard,Marek Kenneth,Eberly Shirley,Oakes David,Kurlan Roger,Ascherio Alberto,Beal Flint,Beck James,Flagg Emily,Galpern Wendy R.,Harman Jennifer,Lang Anthony E.,Schwarzschild Michael,Tanner Caroline,Shoulson Ira

Funder

National Institute of Neurological Disorders and Stroke

Department of Defense Neurotoxin Exposure Treatment Parkinson's Research Program

Michael J. Fox Foundation

Parkinson's Disease Foundation

Cephalon Inc.

Lundbeck Inc.

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mds.25157/fullpdf

Reference30 articles.

1. Progression of Parkinson's disease in the clinical phase: potential markers;Maetzler;Lancet Neurol,2009

2. Biomarkers for Parkinson's [corrected] disease: tools to assess Parkinson's disease onset and progression;Marek;Ann Neurol,2008

3. Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study;Nandhagopal;Brain,2009

4. A longitudinal program for biomarker development in Parkinson's disease: a feasibility study;Ravina;Mov Disord,2009

5. Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease;Parkinson Study Group PRECEPT Investigators;Neurology,2007

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decline in striatal binding ratio associated with accelerated decline in performance on Symbol Digit Modality but not MoCA in Parkinson’s disease psychosis;2024-08-02

2. Reduction in presynaptic dopamine transporter may be associated with future problematic delusion;Clinical Neurology and Neurosurgery;2024-07

3. Resting-state networks and their relationship with MoCA performance in PD patients;Brain Imaging and Behavior;2024-02-09

4. Neurotransmitter function;Reference Module in Neuroscience and Biobehavioral Psychology;2024

5. Pre-clinical Aspects and Contemporary Treatments of Parkinson’s Disease;CNS & Neurological Disorders - Drug Targets;2023-10-06